Related Experiment Video

Updated: Oct 2, 2025

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.3K

COVID-19 vaccine results might inform malaria vaccine strategies

Movin Abeywickrema1, Anna L Goodman2

  • 1Clinical Research Facility, St Thomas' Hospital, Guy's and St Thomas' Foundation Trust, London SE1 7EH, UK.

The Lancet. Infectious Diseases
|February 27, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.2K
An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.4K

Related Experiment Videos

Last Updated: Oct 2, 2025

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.3K
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.2K
An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.4K

Related Concept Videos

Vaccinations01:51

Vaccinations

45.6K
Overview
45.6K

Articles linked to this work by shared authors, journal, and citation graph.

Oxazolidinones in the Clinical Management of Staphylococcal Infection-Linezolid or Tedizolid? A review on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Staphylococci and Staphylococcal Diseases (ESGS).

The Journal of antimicrobial chemotherapy·2026

Comparative serious infection and sepsis risks with advanced therapies in IMIDs: A Bayesian network meta-analysis.

The Journal of infection·2026

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.

Vaccine·2026

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

The New England journal of medicine·2026

Enhancing uptake of respiratory vaccinations in asthma and chronic obstructive pulmonary disease (COPD) patients: a systematic review.

Vaccine·2026

Second-season observations after prophylaxis in the evaluation of the impact of nirsevimab in Galicia (NIRSE-GAL) study: mechanistic interpretation and implications for respiratory syncytial virus prevention strategy.

The Lancet. Infectious diseases·2026

Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks.

The Lancet. Infectious diseases·2026

Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace).

The Lancet. Infectious diseases·2026

When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedside.

The Lancet. Infectious diseases·2026

Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study.

The Lancet. Infectious diseases·2026

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, evaluated with and without tetanus-reduced diphtheria-acellular pertussis vaccine in healthy children aged 6-17 years: a randomised, active-controlled and placebo-controlled, phase 2b trial.

The Lancet. Infectious diseases·2026

Byte-exact, format-aware compression for FASTA, FASTQ, BED and VCF files.

bioRxiv : the preprint server for biology·2026

Interferometric-Based Vital-Sign Signature Identification with ML Validation for Privacy-Preserving Human Detection.

Sensors (Basel, Switzerland)·2026

Complexity of hospital demand during the COVID-19 pandemic in Mexico City.

PloS one·2026

Role of Ion Channels in the Pathophysiology of SARS-CoV-2.

Viruses·2026

Novel Image Encryption Scheme Based on Fireworks Algorithm and Reversible Convolution.

Entropy (Basel, Switzerland)·2026

High Pyrethroid Resistance in Triatoma infestans Is Strongly Associated with kdr Variants: A Multiplex High-Resolution Melting Tool for Vector Surveillance.

Insects·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us